Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
107 studies found for:    "familial isolated pituitary adenoma" OR "Pituitary Neoplasms"
Show Display Options
Rank Status Study
21 Active, not recruiting Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH)
Condition: Pituitary Tumors
Intervention:
22 Unknown  Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma
Condition: Pituitary Tumor
Intervention:
23 Recruiting An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Conditions: Abnormalities;   Craniopharyngioma;   Cushing's Syndrome;   Endocrine Disease;   Pituitary Neoplasm
Intervention:
24 Unknown  Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions
Conditions: Pituitary Neoplasms;   Craniopharyngiomas
Interventions: Drug: Hydrocortisone;   Drug: Prednisone
25 Recruiting Intraoperative Imaging of Pituitary Adenomas by OTL
Conditions: Neoplasms;   Pituitary Neoplasms
Intervention: Drug: OTL38
26 Terminated
Has Results
Rosiglitazone in Treating Patients With Pituitary Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: rosiglitazone maleate
27 Unknown  Genome-wide Association Study of Pituitary Tumors
Condition: Pituitary Adenomas
Intervention:
28 Recruiting Evaluation of Patients With Endocrine-Related Conditions
Conditions: Adrenal Insufficiency;   Pituitary Neoplasm;   Obesity
Intervention:
29 Unknown  The Predictive Factors of Vision Recovery in Patients With Pituitary Tumor
Condition: Pituitary Adenomas
Intervention:
30 Recruiting Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Conditions: Pituitary Adenomas;   Prolactinomas
Intervention: Drug: Lapatinib
31 Withdrawn Temozolomide in Treating Patients With Invasive Pituitary Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Genetic: DNA methylation analysis;   Genetic: microarray analysis;   Genetic: protein expression analysis;   Genetic: proteomic profiling;   Other: laboratory biomarker analysis
32 Terminated Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
Conditions: Growth Hormone Deficiency;   Pituitary Tumor
Intervention:
33 Recruiting Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
Conditions: Pituitary Adenoma;   Pituitary Tumor
Interventions: Procedure: Surgical intervention for CNFA;   Radiation: Radiotherapy for CNFA
34 Completed Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor
Conditions: Cushing's Disease;   Corticotroph Adenoma
Intervention: Drug: Cabergoline
35 Active, not recruiting Peri-Operative Steriod Management in Patients
Conditions: Pituitary Adenoma;   Pituitary Diseases
Interventions: Drug: hydrocortisone;   Drug: dexamethasone
36 Terminated
Has Results
Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
Condition: Cushing's Disease
Intervention: Drug: rosiglitazone maleate
37 Completed Effect of 5 Years of GH Replacement on Atherosclerosis
Conditions: Hypopituitarism;   Pituitary Tumors;   Growth Hormone Deficiency
Intervention: Drug: Recombinant Growth Hormone, Genotropin (Pfizer)
38 Terminated
Has Results
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Conditions: Pancreatic Neoplasm;   Pituitary Neoplasm;   Nelson Syndrome;   Ectopic ACTH Syndrome
Intervention: Drug: pasireotide LAR
39 Completed Evaluation of Factors in Human Brain Tumors
Conditions: Brain Neoplasm;   Glioblastoma;   Glioma;   Pituitary Neoplasm
Intervention:
40 Withdrawn Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
Conditions: Merkel Cell Carcinoma;   Islet Cell Carcinoma;   Neuroendocrine Carcinoma;   Pituitary Tumor
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1;   Procedure: alternative product therapy;   Procedure: biological therapy;   Procedure: biologically based therapies;   Procedure: cancer prevention intervention;   Procedure: complementary and alternative therapy;   Procedure: differentiation therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.